Manning & Napier Life Sciences Fund (EXLSX)

12.34
Net Asset Value
0.00%
1 Day
-4.19%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
No Load
Sales Expenses
1.17%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks to provide long-term growth by investing principally in the common stocks of companies in the life sciences industry. The fund will invest, under normal circumstances, at least 80% of its net assets in securities of companies involved in the life sciences industry. Examples of the companies in which the Series may invest include those in the following areas: pharmaceuticals, biotechnology, medical products and supplies, health care services, and environmental services. The fund may invest in U.S. and foreign stocks, including those in emerging markets, ADRs and other U.S. dollar denominated securities of foreign issuers.

Performance

1 month-0.64% 3 years+10.58%
3 months-0.23% 5 years+19.80%
1 year+19.42% Since inception+12.68%
Data through --

Peer Comparisonvs. Health

 EXLSXCategory
Performance 5-yr return+19.80%+23.71%
Expense ratio1.17%1.46%
Risk 5 year sharpe ratio1.361.54
Net assets$46.4M$2.6B
Average market cap--$31.7B
Average P/E--26.8
Portfolio turnover78%78%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyManning & Napier
Fund manager & tenure-- -- / -- Years
Minimal initial investment$2,000.00
Minimum IRA investment--

Holdings

Cash82.74%
International stock17.26%
U.S. stock0.00%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
Holdings not available.

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.